BNF for Children (BNFC) 2018-2019

Drugs and sport

Anti-doping

UK Anti-Doping, the national body responsible for the UK’s

anti-doping policy, advises that athletes are personally

responsible should a prohibited substance be detected in

their body. Information regarding the use of medicines in

sport is available from:

UK Anti-doping

Fleetbank House

2 - 6 Salisbury Square

London

EC 4 Y 8 AE

( 020 )7842 3450

[email protected]

http://www.ukad.org.uk

Information about the prohibited status of specific

medications based on the current World Anti-Doping

Agency Prohibited List is available from Global Drug

Reference Online:www.globaldro.com/UK/search

General Medical Council’s advice

Doctors who prescribe or collude in the provision of drugs or

treatment with the intention of improperly enhancing an

individual’s performance in sport contravene the GMC’s

guidance, and such actions would usually raise a question of

a doctor’s continued registration. This does not preclude the

provision of any care or treatment where the doctor’s

intention is to protect or improve the patient’s health.

Prescribing in dental practice

General guidance

Advice on the drug management of dental and oral

conditions has been integrated into the main text. For ease

of access, guidance on such conditions is usually identified

by means of a relevant heading (e.g. Dental and Orofacial

Pain) in the appropriate sections.

The following is a list of topics of particular relevance to

dentists.

Prescribing by dentists, see Prescription writing p. 5

Oral side-effects of drugs, see Adverse reactions to drugs

p. 13

Medical emergencies in dental practice, see BNF

Medical problems in dental practice, see BNF

Drug management of dental and oral conditions

Dental and orofacial pain, see Analgesics p. 269

Neuropathic pain p. 293

Non-opioid analgesics and compound analgesic

preparations, see Analgesics p. 269

Opioid analgesics, see Analgesics p. 269

Non-steroidal anti-inflammatory drugs p. 650

Oral infections

Bacterial infections, see Antibacterials, principles of

therapy p. 300

Phenoxymethylpenicillin p. 339

Broad-spectrum penicillins (amoxicillin p. 339 and

ampicillin p. 341 )

Cephalosporins (cefalexin p. 317 and cefradine p. 318 )

Tetracyclines p. 351

Macrolides (clarithromycin p. 330 , erythromycin

p. 331 and azithromycin p. 329 )

Clindamycin p. 327

Metronidazole p. 333

Fusidic acid p. 357

Fungal infections

Local treatment, see Oropharyngeal fungal infections

p. 709

Systemic treatment, see Antifungals, systemic use

p. 370

Viral infections

Herpetic gingivostomatitis, local treatment, see

Oropharyngeal viral infections p. 711

Herpetic gingivostomatitis, systemic treatment, see

Oropharyngeal viral infections p. 711 and Herpesvirus

infections p. 403

Herpes labialis, see Skin infections p. 720

Anaesthetics, anxiolytics and hypnotics

Sedation, anaesthesia, and resuscitation in dental

practice p. 804

Hypnotics, see Hypnotics and anxiolytics p. 293

Sedation for dental procedures, see Hypnotics and

anxiolytics p. 293

Anaesthesia (local) p. 822

Minerals

Fluorides p. 705

Oral ulceration and inflammation p. 706

Mouthwashes and gargles, see Mouthwashes and

other preparations for oropharyngeal use p. 703

Dry mouth, see Treatment of dry mouth p. 701

Aromatic inhalations, see Aromatic inhalations,

cough preparations and systemic nasal decongestants

p. 187

Nasal decongestants, see Aromatic inhalations, cough

preparations and systemic nasal decongestants p. 187

Dental Practitioners’Formulary p. 1056

24 Drugs and sport BNFC 2018 – 2019

Drugs and sport